These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 32293065)

  • 1. A multicenter randomized controlled trial of medium-chain triglyceride dietary supplementation on epilepsy in dogs.
    Berk BA; Law TH; Packer RMA; Wessmann A; Bathen-Nöthen A; Jokinen TS; Knebel A; Tipold A; Pelligand L; Meads Z; Volk HA
    J Vet Intern Med; 2020 May; 34(3):1248-1259. PubMed ID: 32293065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A double-blinded randomised dietary supplement crossover trial design to investigate the short-term influence of medium chain fatty acid (MCT) supplement on canine idiopathic epilepsy: study protocol.
    Berk BA; Packer RMA; Law TH; Wessmann A; Bathen-Nöthen A; Jokinen TS; Knebel A; Tipold A; Pelligand L; Volk HA
    BMC Vet Res; 2019 May; 15(1):181. PubMed ID: 31146740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomised trial of a medium-chain TAG diet as treatment for dogs with idiopathic epilepsy.
    Law TH; Davies ES; Pan Y; Zanghi B; Want E; Volk HA
    Br J Nutr; 2015 Nov; 114(9):1438-47. PubMed ID: 26337751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy evaluation of a commercially available MCT enriched therapeutic diet on dogs with idiopathic epilepsy treated with zonisamide: a prospective, randomized, double-blinded, placebo-controlled, crossover dietary preliminary study.
    Nakatsuka K; Zanghi B; Hasegawa D
    BMC Vet Res; 2023 Sep; 19(1):145. PubMed ID: 37674206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of medium chain triglyceride oil dietary supplementation in reducing seizure frequency in dogs with idiopathic epilepsy without cluster seizures: a non-blinded, prospective clinical trial.
    Molina J; Jean-Philippe C; Conboy L; Añor S; de la Fuente C; Wrzosek MA; Spycher A; Luchsinger E; Wenger-Riggenbach B; Montoliu P; Gandini G; Menchetti M; Ribeiro JC; Varejão A; Ferreira A; Zanghi B; Volk HA
    Vet Rec; 2020 Oct; 187(9):356. PubMed ID: 32532842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of a ketogenic diet on ADHD-like behavior in dogs with idiopathic epilepsy.
    Packer RM; Law TH; Davies E; Zanghi B; Pan Y; Volk HA
    Epilepsy Behav; 2016 Feb; 55():62-8. PubMed ID: 26773515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medium-chain triglycerides dietary supplement improves cognitive abilities in canine epilepsy.
    Berk BA; Packer RMA; Law TH; Wessmann A; Bathen-Nöthen A; Jokinen TS; Knebel A; Tipold A; Pelligand L; Volk HA
    Epilepsy Behav; 2021 Jan; 114(Pt A):107608. PubMed ID: 33268017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigating owner use of dietary supplements in dogs with idiopathic epilepsy.
    Berk BA; Packer RMA; Law TH; Volk HA
    Res Vet Sci; 2018 Aug; 119():276-284. PubMed ID: 30064067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic fingerprinting of dogs with idiopathic epilepsy receiving a ketogenic medium-chain triglyceride (MCT) oil.
    Berk BA; Ottka C; Hong Law T; Packer RMA; Wessmann A; Bathen-Nöthen A; Jokinen TS; Knebel A; Tipold A; Lohi H; Volk HA
    Front Vet Sci; 2022; 9():935430. PubMed ID: 36277072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A six-month prospective, randomised, double-blinded, placebo-controlled, crossover, dietary trial design to investigate the potential of psychobiotics on seizure semiology and comorbidities in canine epilepsy: study protocol.
    Schmidt T; Meller S; Meyerhoff N; Twele F; Zanghi B; Volk HA
    BMC Vet Res; 2023 Mar; 19(1):57. PubMed ID: 36864510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of levetiracetam as adjunctive treatment for refractory canine epilepsy: a randomized, placebo-controlled, crossover trial.
    Muñana KR; Thomas WB; Inzana KD; Nettifee-Osborne JA; McLucas KJ; Olby NJ; Mariani CJ; Early PJ
    J Vet Intern Med; 2012; 26(2):341-8. PubMed ID: 22295869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic perturbations associated with the consumption of a ketogenic medium-chain TAG diet in dogs with idiopathic epilepsy.
    Law TH; Volk HA; Pan Y; Zanghi B; Want EJ
    Br J Nutr; 2018 Sep; 120(5):484-490. PubMed ID: 30001753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The efficacy and safety of cannabidiol as adjunct treatment for drug-resistant idiopathic epilepsy in 51 dogs: A double-blinded crossover study.
    Rozental AJ; Weisbeck BG; Corsato Alvarenga I; Gustafson DL; Kusick BR; Rao S; Bartner LR; McGrath S
    J Vet Intern Med; 2023; 37(6):2291-2300. PubMed ID: 37889215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Felbamate as an oral add-on therapy in six dogs with presumptive idiopathic epilepsy and generalized seizures resistant to drug therapy.
    Dewey CW; Rishniw M; Sakovitch K
    Open Vet J; 2022; 12(4):445-450. PubMed ID: 36118733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Telmisartan as an add-on treatment for dogs with refractory idiopathic epilepsy: a nonrandomized, uncontrolled, open-label clinical trial.
    Hanael E; Chai O; Konstanitin L; Gibeon L; Rapaport K; Ruggeri M; Friedman A; Shamir MH
    J Am Vet Med Assoc; 2022 Feb; 260(7):735-740. PubMed ID: 35201995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seizures in dogs under primary veterinary care in the United Kingdom: Etiology, diagnostic testing, and clinical management.
    Erlen A; Potschka H; Volk HA; Sauter-Louis C; O'Neill DG
    J Vet Intern Med; 2020 Nov; 34(6):2525-2535. PubMed ID: 33128852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenobarbital or potassium bromide as an add-on antiepileptic drug for the management of canine idiopathic epilepsy refractory to imepitoin.
    Royaux E; Van Ham L; Broeckx BJ; Van Soens I; Gielen I; Deforce D; Bhatti SF
    Vet J; 2017 Feb; 220():51-54. PubMed ID: 28190495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imepitoin withdrawal in dogs with idiopathic epilepsy well-controlled with imepitoin and phenobarbital and/or potassium bromide does not increase seizure frequency.
    Stee K; Martlé V; Broeckx BJG; Royaux E; Van Ham L; Bhatti SFM
    Vet J; 2017 Dec; 230():1-5. PubMed ID: 29208209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized blinded controlled clinical trial to assess the effect of oral cannabidiol administration in addition to conventional antiepileptic treatment on seizure frequency in dogs with intractable idiopathic epilepsy.
    McGrath S; Bartner LR; Rao S; Packer RA; Gustafson DL
    J Am Vet Med Assoc; 2019 Jun; 254(11):1301-1308. PubMed ID: 31067185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prospective observational longitudinal study of new-onset seizures and newly diagnosed epilepsy in dogs.
    Fredsø N; Toft N; Sabers A; Berendt M
    BMC Vet Res; 2017 Feb; 13(1):54. PubMed ID: 28209153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.